| Dr Lawrence I Russell, MD | |
|
4212 West Congress Street, Suite 1401, Lafayette, LA 70506 | |
| (337) 981-8131 | |
| (337) 989-1316 |
| Full Name | Dr Lawrence I Russell |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 4212 West Congress Street, Lafayette, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407853237 | NPI | - | NPPES |
| 1167169 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 014024 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lawrence I Russell, MD 4212 West Congress Street, Suite 1401, Lafayette, LA 70506 Ph: (337) 981-8131 | Dr Lawrence I Russell, MD 4212 West Congress Street, Suite 1401, Lafayette, LA 70506 Ph: (337) 981-8131 |
News Archive
Nearly one-fourth of cigarette smokers believe that so-called reduced-exposure tobacco products - such as "light," herbal or reduced nicotine cigarettes - are less harmful to their health than conventional cigarettes, a new study finds. However, such beliefs are not backed up by existing evidence, according to the study's authors.
Calling professional medical associations' (PMAs) dependence on funding from pharmaceutical and medical device manufacturers a threat to quality patient care and professional integrity, a group of influential medical leaders today urged these organizations to reduce and eventually eliminate industry contributions.
BIOLASE Technology, Inc. today announced that it finalized three regional distribution agreements in the People's Republic of China. This announcement follows the Company's August 12, 2009, announcement that it had received regulatory approval to market its Waterlase MD™ products in China.
Pfizer Inc. announced today that the Phase 3 AXIS 1032 trial (A4061032), studying the investigational compound axitinib in previously treated patients with metastatic renal cell carcinoma (mRCC), has met its primary endpoint, demonstrating that axitinib significantly extended progression-free survival when compared to sorafenib, in the study population.
Prescription rates for hormone replacement therapy (HRT) are lower in more deprived areas of England compared to affluent areas, a new study from the University of Warwick has found.
› Verified 2 days ago
Dr. Maximo Bienvenido Lamarche, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 300 W Saint Mary Blvd, Lafayette, LA 70506 Phone: 337-233-6593 Fax: 337-235-1032 | |
Dr. John M Rainey, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 501 W Saint Mary Blvd, Lafayette, LA 70506 Phone: 337-235-7898 Fax: 337-235-7445 | |
Dr. Corwin Ashford Thomas, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 802 E Farrel Rd, Lafayette, LA 70508 Phone: 337-234-3163 Fax: 337-234-3168 | |
Dr. Matthew Shane Fontenot, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1214 Coolidge Blvd, Lafayette, LA 70503 Phone: 337-289-7927 Fax: 337-289-7935 | |
Dr. John Brent Rhodes Jr., M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 439 Heymann Blvd, Lafayette, LA 70503 Phone: 337-269-0963 Fax: 337-269-0553 | |
Leela P. Lakshmiprasad, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: Lsu Medicine Clinic, 2390 W Congress Street, Lafayette, LA 70506 Phone: 337-261-6100 | |
Dr. Kamalendra Nath Mondal, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 3149 Ambassador Caffery Pkwy, Lafayette, LA 70506 Phone: 337-706-3415 |